Is pharma industry awaiting a roller coaster ride? | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
June 12, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JUNE 12, 2025
Is pharma industry awaiting a roller coaster ride?

Supplement

Mahfuz Ullah Babu
29 September, 2024, 12:45 pm
Last modified: 29 September, 2024, 12:50 pm

Related News

  • Gas supply to industries increased, to keep improving: Energy adviser
  • Pay your workers by 28 May or prepare for jail: Adviser Sakhawat to factory owners
  • Lotto inaugurates new factory to nearly triple production capacity
  • Semiconductor industry eyes $1b export by 2030, seeks govt backing, policy changes
  • FICCI president says next budget an opportunity to boost investor confidence

Is pharma industry awaiting a roller coaster ride?

The $175 million export in the FY 2022-23 is expected to grow to $450 million in 2025 and the companies like Square, Incepta, Beximco, Renata, ACI, among others have their strengths to take it to $1.5 billion by 2030 as expected earlier

Mahfuz Ullah Babu
29 September, 2024, 12:45 pm
Last modified: 29 September, 2024, 12:50 pm
Representational Image. Photo: Collected
Representational Image. Photo: Collected

The pharmaceuticals industry made Bangladesh a unique story among all least developed countries (LDC) in terms of self-sufficiency in medicines as the local industry ascended to cater 98% of local demand, from less than 10% in early 1980s.

Moreover, Bangladeshi drug makers, already reaching around 150 countries as exporters, have been fast enough in their mission for national export diversification.

The gigantic home market, already surpassing the $3 billion milestone, is being expected to grow to over $6.5 billion before 2028. Setting aside the Ukraine War shocks that hurt all businesses in the past two years, the pharmaceuticals industry tripled their exports in the past decade.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The $175 million export in the FY 2022-23 is expected to grow to $450 million in 2025 and the companies like Square, Incepta, Beximco, Renata, ACI, among others have their strengths to take it to $1.5 billion by 2030 as expected earlier.

Major industry players are looking at the empty half of the glass. There are significant challenges in both the markets home and abroad that need to be proactively addressed and that should be under a stronger collaboration of the government, industry and the academia.

The national drug policy of 1982 helped the self-dependency as Bangladesh as an LDC got a waiver from paying patent fees to the giant international companies innovating new products and having their patents on for up to two decades.

If Bangladesh graduates from its LDC status in 2026, there is a risk of losing the cost edge after 2028 as it is yet to get any time extension.

Besides, the world is getting ready to come out of the waiver at the end of 2032 which was granted through the Trade-related Intellectual Property Rights (TRIPS) agreement at the World Trade Organization.

In 2029 or 2033, Bangladeshi drug makers will have to pay huge fees to the patent-holder companies against producing the generic versions of their patent-on drugs.

Mohammad Atiquzzaman, marketing director of Square Pharmaceuticals said to TBS, about 20% of the drugs in production in Bangladesh were still patented and the fees might increase the cost and price by several folds for some of them.

The local market may see a sharp price hike post TRIPS waiver for the products, he said.

Better, the government bargain strongly for the waiver extension till 2032-33, said S M Shafiuzzaman, secretary general of the Bangladesh Association of Pharmaceutical Industries (BAPI) that represents over 150 companies.  

A rising demand, especially in developed markets, for products with bio equivalence certification will add to costs, resources and investments in capacity building, said Atiquzzaman, adding that the cost of international compliances is high and that should be followed by export growth. 

The industry still depends on imports for 97% of the active pharmaceutical ingredients (API)- the semi-finished raw material it uses to produce medicines. The frustrating pace of the API Industrial Park in Munshiganj that should have started much before dragged the industry back in competing with giants like China, India.

API making must be efficient, said Atiquzzaman.

"Still, we have opportunities that should not be missed anymore," said Shafiuzzaman.

To avert high patent fees post waiver, the industry can start producing generic formulations of the drugs under patent before LDC graduation, he said, adding, also being the first generic maker will help boost export performance.

Each of the opportunities will be subject to success in investments and capacity building that demand companies' strong financial health and collective efforts, according to them.

Top News

pharmacy / industry / world heart day

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Govt to set up Debt Office as loan burden to hit Tk29 lakh cr by FY28
    Govt to set up Debt Office as loan burden to hit Tk29 lakh cr by FY28
  • UK Secretary of State for Business and Trade and President of the Board of Trade Jonathan Reynolds meets Chief Adviser Muhammad Yunus on 11 June 2025. Photo: UNB
    UK reaffirms support for Bangladesh's initiatives to recover siphoned off money
  • File Photo of Chief Adviser Muhammad Yunus: UNB
    Prof Yunus to receive Harmony Award from King Charles today

MOST VIEWED

  • File photo of ex-prime minister Sheikh Hasina and her son Sajeeb Wazed Joy. Photo: Collected
    Joy spends Eid with Hasina in India: Indian media
  • Infofgraphics: TBS
    DGHS issues 11-point directive to prevent spread of Covid-19 in Bangladesh
  • Saifuzzaman Chowdhury. Photo: Collected
    UK crime agency now freezes assets of ex-land minister Saifuzzaman: AJ
  • File photo of BNP Standing Committee Member Amir Khasru Mahmud Chowdhury. Photo: Collected
    Khasru flies to London ahead of Yunus-Tarique meeting
  • Chief Adviser Muhammad Yunus speaks at the Chatham House in London on 11 June 2025. Photo: CA Press Wing
    No desire to be part of next elected govt: CA Yunus
  • Illustration: Khandaker Abidur Rahman/TBS
    Three hospitals ‘held hostage’ as discharged July uprising injured keep occupying beds

Related News

  • Gas supply to industries increased, to keep improving: Energy adviser
  • Pay your workers by 28 May or prepare for jail: Adviser Sakhawat to factory owners
  • Lotto inaugurates new factory to nearly triple production capacity
  • Semiconductor industry eyes $1b export by 2030, seeks govt backing, policy changes
  • FICCI president says next budget an opportunity to boost investor confidence

Features

Among pet birds in the country, lovebirds are the most common, and they are also the most numerous in the haat. Photo: Junayet Rashel

Where feathers meet fortune: How a small pigeon stall became Dhaka’s premiere bird market

17h | Panorama
Illustration: Duniya Jahan/ TBS

Forget Katy Perry, here’s Bangladesh’s Ruthba Yasmin shooting for the moon

1d | Features
File photo of Eid holidaymakers returning to the capital from their country homes/Rajib Dhar

Dhaka: The city we never want to return to, but always do

3d | Features
Photo collage shows political posters in Bagerhat. Photos: Jannatul Naym Pieal

From Sheikh Dynasty to sibling rivalry: Bagerhat signals a turning tide in local politics

4d | Bangladesh

More Videos from TBS

What did the Chief Advisor do on the second day of his UK visit?

What did the Chief Advisor do on the second day of his UK visit?

44m | TBS Stories
Why is Omicron XBB more contagious?

Why is Omicron XBB more contagious?

14h | TBS Stories
What did Dr. Yunus say at the Chatham House Dialogue in London?

What did Dr. Yunus say at the Chatham House Dialogue in London?

15h | TBS Today
News of The Day, 11 JUNE 2025

News of The Day, 11 JUNE 2025

16h | TBS News of the day
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net